Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance

OncoImmunology

Volumn 5, Issue 5, 2016, Pages

  Dagenais, Maryse ^a   Saleh, Maya ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cancer; Fas; Immunosurveillance; Immunotherapy; Innate immunity; NK cells; Nlrp3 inflammasome

Indexed keywords

CRYOPYRIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; CYTOTOXIC LYMPHOCYTE; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; KUPFFER CELL; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84965076090     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1129484     Document Type: Review

References (10)

1. E.Vivier, S.Ugolini, D.Blaise, C.Chabannon, L.Brossay. Targeting natural killer cells and natural killer T cells in cancer. Nat. Rev. (2012); 12:239–52; PMID:22437937; http://dx.doi.org/10.1038/nri3174
2. I.Melero. D.M.Berman, M.A.Aznar, A.J.Korman, J.L.Pérez Gracia, J.Haanen. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat. Rev. Cancer (2015); 15:457–72; PMID:26205340; http://dx.doi.org/10.1038/nrc3973
3. E.Latz, T.S.Xiao, A.Stutz. Activation and regulation of the inflammasomes. Nat. Rev. (2013); 13:397–411; PMID:23702978; http://dx.doi.org/10.1038/nri3452
4. A.Kent, J.M.Blander. Nod-like receptors: key molecular switches in the conundrum of cancer. Front. Immunol. (2014); 5:185; PMID:24795727; http://dx.doi.org/10.3389/fimmu.2014.00185
5. M.Saleh, G.Trinchieri. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat. Rev. (2011); 11:9–20; PMID:21151034; http://dx.doi.org/10.1038/nri2891
6. M.T.Carrascal. L.Mendoza, M.Valcárcel, C.Salado, E.Egilegor, N.Tellería, F.Vidal-Vanaclocha, C.A.Dinarello. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res. (2003); 63:491–7; PMID:12543807
7. M.Terme, E.Ullrich, L.Aymeric, K.Meinhardt, J.D.Coudert, M.Desbois, F.Ghiringhelli, S.Viaud, B.Ryffel, H.Yagita Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells. Cancer Res. (2012); 72:2757–67; PMID:22427351; http://dx.doi.org/10.1158/0008-5472.CAN-11-3379
8. F.Ghiringhelli, L.Apetoh, A.Tesniere, L.Aymeric, Y.Ma, C.Ortiz, K.Vermaelen, T.Panaretakis, G.Mignot, E.Ullrich Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. (2009); 15:1170–8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
9. J.Garaude, A.Kent, N.van Rooijen, J.M.Blander. Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses. Sci Transl Med. (2012); 8;4(120): 120ra16; PMID:22323829; http://dx.doi.org/10.1126/scitranslmed.3002868
10. J.Dupaul-Chicoine, A.Arabzadeh, M.Dagenais, T.Douglas, C.Champagne, A.Morizot, I.G.Rodrigue-Gervais, V.Breton, S.L.Colpitts, N.Beauchemin The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity (2015); 43:751–63; PMID:26384545; http://dx.doi.org/10.1016/j.immuni.2015.08.013